This clinical study is testing a potential new treatment for the prevention of thromboembolic events (blood clots).
Thrombosis, the formation of harmful blood clots, is a major health concern worldwide, responsible for about 1 in 4 deaths. These clots can block blood flow in important blood vessels, leading to serious complications such as heart attacks, strokes, or pulmonary embolism.
The purpose of the study is to evaluate the safety and tolerability of the study drug in healthy adult participants.
Be 18 to 65 years old
Both males or females
